A novel phenylaminotetralin (PAT) recognizes histamine H1 receptors and stimulates dopamine synthesis in vivo in rat brain

Brain Research

Volumn 852, Issue 1, 2000, Pages 151-160

  Choksi, Neepa Y ^a   Nix, William B ^a   Wyrick, Steven D ^a   Booth, Raymond G ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Aminotetralin; Catecholamine; Dopamine; Histamine; Phenylaminotetralin; Tyrosine hydroxylase

Indexed keywords

CATECHOLAMINE; DOPAMINE; HISTAMINE H1 RECEPTOR; TETRALIN DERIVATIVE; TRIPROLIDINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; DOPAMINE METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRAPYRAMIDAL SYSTEM; FEEDBACK SYSTEM; LIGAND BINDING; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; CORPUS STRIATUM; DOPAMINE; KINETICS; LIGANDS; NUCLEUS ACCUMBENS; PYRILAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H1; TETRAHYDRONAPHTHALENES;

EID: 0033966838     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02228-3     Document Type: Article

References (34)

1. Baldessarini R.J., Marsh E.R., Kula N.S., Zong R., Gao Y., Neumeyer J.L. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions. Biochem. Pharmacol. 40:1990;417-423.
2. Booth R.G., Brown R.L., Bucholtz E.C., Choksi N.Y., Owens C.E., Wyrick S.D. Phenylaminotetralins: a new class of histamine H1-type ligands that affect catecholamine synthesis and release in vitro and in vivo. Soc. Neurosci. Abstr. 24:1998;1838.
3. 3H ]-(-)-trans-1-phenyl-3-aminotetralin (PAT) Brain Res. 837:1999;95-105.
4. Booth R.G., Baldessarini R.J. (+)-6,7-Benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Res. 557:1991;349-352.
5. 2 autoreceptor activation. Eur. J. Pharmacol. 185:1990;217-221.
6. Booth R.G., Wyrick S.D., Baldessarini R.J., Kula N.S., Myers A.M., Mailman R.B. New σ-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies. Mol. Pharmacol. 44:1993;1232-1239.
7. Booth R.G., Baldessarini R.J., Kula N.S., Zong R., Gao Y., Neumeyer J.L. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Mol. Pharmacol. 38:1990;92-101.
8. Bucholtz E.C., Wyrick S.D., Owens C.E., Booth R.G. 1-Phenyl-3-dimethylaminotetralins (PATs): effect of stereochemistry on binding and function at brain histamine receptors. Med. Chem. Res. 8:1998;322-332.
9. 3H ]mepyramine binding of brain membranes J. Neurochem. 32:1979;1653-1663.
10. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
11. 2 receptors. Brain Res. 761:1997;151-155.
12. 1-type receptor. Soc. Neurosci. Abstr. 23:1997;2068.
13. 1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;50-54.
14. K. Fuxe, L.F. Agnati, M. Kalia, M. Goldstein, K. Andersson, A. Harfstrand, Dopaminergic systems in the brain and periphery, in: Basic and Clinical Aspects of Neuroscience, Springer-Verlag, Berlin, 1997, pp. 11-25.
15. 1 agonist containing a rigid β-phenyldopamine pharmacophore. J. Med. Chem. 39:1996;549-555.
16. Kenakin T. Agonist-receptor efficacy: I. Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci. 16:1995;188-192.
17. Kenakin T. Agonist-receptor efficacy: II. Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16:1995;231-238.
18. 1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines, and analogues. J. Med. Chem. 38:1995;1287-1294.
19. L.E., Limbird, Identification of receptors using direct radioligand binding techniques, in: Cell Surface Receptors: A Short Course on Theory and Methods, Martinus Nijhoff Publishing, Boston, 1985, pp. 88-94.
20. 3 receptor. J. Med. Chem. 37:1994;4109-4117.
21. 1 properties. Soc. Neurosci. Abstr. 22:1996;2006.
22. 2-PAT Soc. Neurosci. Abstr. 20:1994;748.
23. 3H ]-mepyramine: preliminary studies Eur. J. Pharmacol. 58:1979;295-304.
24. Popick F.R. Application of a new intraventricular injection technique in rat brain norepinephrine studies. Life Sci. 18:1976;197-203.
25. Richelson E. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J. Clin. Psychiatry. 57:1996;4-11. Suppl. 11.
26. Seeman P., Grigoriadis D. Dopamine receptors in brain and periphery. Neurochem. Int. 10:1987;1-25.
27. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
28. 116 (TM3) has a constitutive role in receptor stimulation. J. Comput.-Aided Mol. Des. 9:1995;319-330.
29. 3H ]mepyramine Proc. Natl. Acad. Sci. U. S. A. 75:1978;6290-6294.
30. Walters J.R., Roth R.H. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 296:1976;5-14.
31. Wolf M.E., Roth R.H. Autoreceptor regulation of dopamine synthesis. Ann. N. Y. Acad. Sci. 604:1990;323-342.
32. Wyrick S.D., Booth R.G., Myers A.M., Owens C.E., Kula N.S., Baldessarini R.J., Mailman R.B. Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with σ-like modulatory activity. J. Med. Chem. 36:1993;2542-2551.
33. 2-PAT) J. Labelled Compd. Radiopharm. 34:1994;131-134.
34. 1 receptor antagonists, in: M.E. Wolff, (Ed.), Burgers Medicinal Chemistry and Drug Discovery, 5th edn., Vol. 5, Wiley, New York, 1997, pp. 495-559.